Table 1 Participant characteristics
| Â | Metabolic Syndrome | ||
|---|---|---|---|
|  | No (n = 1586) | Yes (n = 984) | |
Age, years | 58 ± 9 | 62 ± 9 | |
Women, % | 60 | 52 | |
Body mass index, kg/m2 | 25.9 ± 4.2 | 30.5 ± 5.0 | |
Mean waist, cm | 93 ± 12 | 106 ± 11 | |
Systolic blood pressure, mmHg | 120 ± 17 | 133 ± 18 | |
| Â | Â | 22 | 64 |
Hypertension treatment, % | 15 | 44 | |
| Â | Â | 14 | 11 |
Triglycerides, mg/dl | 101 ± 53 | 171 ± 91 | |
Total/HDL cholesterol | 3.5 ± 1.0 | 4.6 ± 1.3 | |
Lipid treatment, % | 5 | 27 | |
Aspirin use, % | 22 | 29 | |
Hormone replacement therapy, % | 20 | 16 | |
Metabolic syndrome components, % (n) | |||
Elevated waist circumference | ≥102 cm in men, ≥88 cm in women | 41 (655) | 88 (862) |
Elevated triglycerides | ≥150 mg/dL | 16 (248) | 69 (679) |
Low HDL | <40 mg/dL in men, <50 mg/dL in women | 11 (169) | 53 (522) |
High blood pressure | Systolic BP ≥130, diastolic BP ≥85 mmHg or treatment | 32 (502) | 79 (778) |
Hyperglycemia | Fasting glucose ≥100 and <126 mg/dL | 17 (273) | 67 (661) |